AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 237 filers reported holding AMICUS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,310,291 | -13.6% | 189,991 | -10.7% | 0.01% | -11.1% |
| Q2 2023 | $2,672,429 | +35.6% | 212,773 | +19.7% | 0.01% | +28.6% |
| Q1 2023 | $1,971,314 | -19.2% | 177,756 | -11.0% | 0.01% | -22.2% |
| Q4 2022 | $2,439,411 | +16.9% | 199,788 | 0.0% | 0.01% | +12.5% |
| Q3 2022 | $2,086,000 | -33.1% | 199,788 | -31.2% | 0.01% | -33.3% |
| Q2 2022 | $3,120,000 | +13.4% | 290,481 | 0.0% | 0.01% | +33.3% |
| Q1 2022 | $2,751,000 | -3.8% | 290,481 | +17.3% | 0.01% | +12.5% |
| Q4 2021 | $2,861,000 | +16.2% | 247,674 | -4.0% | 0.01% | 0.0% |
| Q3 2021 | $2,463,000 | -5.1% | 257,868 | -4.2% | 0.01% | 0.0% |
| Q2 2021 | $2,594,000 | +71.7% | 269,082 | +75.9% | 0.01% | +60.0% |
| Q1 2021 | $1,511,000 | -58.9% | 152,955 | -3.8% | 0.01% | -61.5% |
| Q4 2020 | $3,672,000 | +49.1% | 159,032 | -8.8% | 0.01% | +30.0% |
| Q3 2020 | $2,462,000 | -15.2% | 174,342 | -9.5% | 0.01% | -16.7% |
| Q2 2020 | $2,904,000 | +36.6% | 192,581 | -16.3% | 0.01% | +20.0% |
| Q1 2020 | $2,126,000 | -5.1% | 230,099 | 0.0% | 0.01% | +25.0% |
| Q4 2019 | $2,241,000 | +47.6% | 230,099 | +21.6% | 0.01% | +33.3% |
| Q3 2019 | $1,518,000 | – | 189,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Diversified Trust Co | 62,695 | $889,642 | 0.03% |
| FULTON BANK, N.A. | 11,429 | $162,177 | 0.01% |
| DnB Asset Management AS | 24,836 | $352,423 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 78 | $1,107 | 0.00% |
| Versant Capital Management, Inc | 28 | $397 | 0.00% |